Life Sciences
2 articles
Strategy
Single-Cell CRISPR Assays Market Poised to Surpass $1 Billion by 2028
Researchers can now pinpoint how individual cells respond to gene edits, a capability previously impossible with bulk sequencing, unlocking a new era of precision medicine, according to Cell Journal .
Priya Sen·June 8, 2026
Strategy
Life Sciences Must Build A Business Case For Health Outcomes
Over 20% of all U.S. prescriptions are never filled. For high-cost therapies, this problem intensifies: 60% of prescriptions costing $500 or more out-of-pocket are abandoned, according to Healthcare I
Priya Sen·June 4, 2026